FINWIRES · TerminalLIVE
FINWIRES

$AGL

8 stories mentioning AGLUpdated 5d ago

Every FINWIRES story that references AGL, newest first.

Research

Citigroup Upgrades Agilon Health to Neutral From Sell, Adjusts Price Target to $115 From $105

agilon health (AGL) has an average rating of hold and mean price target of $110.92, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$AGL
Sectors

Sector Update: Healthcare Stocks Rise Late Afternoon

Healthcare stocks advanced late Thursday afternoon with the NYSE Healthcare Index gaining 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) rising 1.1%.The iShares Biotechnology ETF (IBB) added 1%.In corporate news, Thermo Fisher Scientific (TMO) shares jumped 8.9% after fiscal Q2 adjusted earnings and revenue topped estimates.Quest Diagnostics (DGX) shares rose 8% after Q2 adjusted earnings and revenue exceeded market consensus.Neuphoria Therapeutics (NEUP) agreed to be acquired by Scancell Holdings in an all-stock deal. Neuphoria shares jumped 15%.Agilon Health (AGL) shares fell 14% after Citigroup downgraded the stock to sell from neutral and lifted its price target to $105 from $80.

$AGL$DGX$NEUP$TMO
Sectors

Sector Update: Healthcare

Healthcare stocks were higher late Thursday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each rising 1.1%.The iShares Biotechnology ETF (IBB) added 0.9%.In corporate news, Agilon Health (AGL) shares fell 15% after Citigroup downgraded the stock to sell from neutral, and adjusted its price target to $105 per share from $80.

$AGL
Wire

Agilon Health Shares Fall After Citigroup Downgrade

Agilon Health (AGL) shares fell about 14% in Thursday trading after Citigroup downgraded the stock to sell from neutral, and adjusted its price target to $105 per share from $80 earlier.Trading volume stood at about 305,200 shares, compared with a daily average of over 404,372.Price: $103.14, Change: $-16.75, Percent Change: -13.97%

$AGL
Research

Citigroup Downgrades Agilon health to Sell From Neutral, Adjusts Price Target to $105 From $80

$AGL
Wire

Top Midday Gainers

Agilon Health (AGL) reported late Wednesday higher Q1 earnings, while Deutsche Bank also upgraded the company to buy from hold and raised its price target to $49 from $33.Shares more than doubled Thursday as intraday trading volume catapulted to over 3.2 million from a daily average of about 335,000.SiTime (SITM) reported stronger-than-expected Q1 adjusted earnings and revenue late Wednesday.Shares soared 25%, with intraday trading volume of over 956,200 from a daily average of about 421,000.Datadog (DDOG) raised its full-year outlook while reporting Q1 non-GAAP earnings and revenue above analysts' estimates.Shares surged 29% as intraday trading volume soared to over 19.8 million from a daily average of roughly 5.4 million.Price: $62.25, Change: $+34.40, Percent Change: +123.50%

$AGL$DDOG$SITM
Research

Jefferies Upgrades agilon health to Buy From Hold, Adjusts Price Target to $48 From $27.50

agilon health (AGL) has an average rating of hold and mean price target of $27.14, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$AGL
Research

Deutsche Bank Upgrades Agilon Health to Buy From Hold, Adjusts Price Target to $49 From $33

agilon health inc (AGL) has an average rating of Hold and mean price target of $27.14, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$AGL

Track with the FINWIRES app suite